For the biopharma industry, 2018 was a year marked by generally robust profits and a handful of superlatives.
Pharma's 2019 Prognosis Hinges on These Key Themes
Comment
Show comments
Hide Comments
For the biopharma industry, 2018 was a year marked by generally robust profits and a handful of superlatives.
